In a study by Kalita et al., patients with WD have been shown to have higher levels of malondialdehyde (MDA), glutamate, and cytokines (IL-6, IL-8, IL-10 and TNF-α), and lower levels of GSH and weaker total antioxidant capacity (TAC) compared to the control group. This evidence concerns the gene IL6 and Wilson disease.